Table 6.

Neuroimaging findings

SL. no	Imaging type	Findings
1	CT	NAD- [Panariello et al. 2020, Yin et al. 2020, McAbee et al. 2020, Ye et al. 2020, Duong et al. 2020, Pilotto et al. 2020, Mukhergee et al. 2020] Haemorrhagic- Frontal EDH [Al-olama et al. 2020] Ischemic- Right caudate nucleus [Morassi et al. 2020] Chronic microvascular change [Sohal and Mossamat 2020]
2	MRI	NAD-[ref-Chaumont et al. 2020, Karimi et al. 2020, Dogan et al. 2020 (case no 3,4,5), Bernard-Valnet et al. 2020] T2 [Wong et al. 2020,Afshar et al. 2020, Efe et al. 2020] or T2 /FLAIR hyperintensity-[ref-Efe et al. 2020, Moriguchi et al. 2020, Morassi et al. 2020, Ramero-Sanchez et al. 2020] Encephalitis like feature (hyperintensity, enhancement, haemorrhage) [Dogan et al. 2020 (case nos 1, 2, 6)] DWI Restriction/ADC hypodensity [Moriguchi et al. 2020, Hayashi et al. 2020]
3	Angiography	CTA Beaded appearance-[Al-aloma et al. 2020] MRA NA
5	MRS	Choline peak-[Efe et al. 2020]
4	Not available	[Pilotto et al. 2020, Packwood et al. 2020, Chacon-Aguillar 2020, Talmor et al. 2020, Romrero-Sanchez et al. 2020, Varatharaj et al. 2020]

CT computed tomography, MRI magnetic resonance imaging, MRS magnetic resonance spectroscopy, NAD no appreciable disease, FLAIR hyperintensity fluid attenuated inversion recovery hyperintensity, DWI diffusion-weighted imaging, ADC apparent diffusion coefficient, CTA computed tomography angiography, MRA magnetic resonance angiography